Sirolimus for Focal Segmental Glomerulosclerosis

NCT00040508 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Focal Glomerulosclerosis

Interventions

DRUG: Sirolimus

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)